The recent demonstration that primary cells from the liver can be expanded in vitro as organoids holds enormous promise for regenerative medicine and disease modeling 1-5 . The use of threedimensional (3D) cultures based on ill-defined and potentially immunogenic matrices, however, hampers the translation of liver organoid technology into real-life applications 6 . We here used chemically defined hydrogels for the efficient derivation of both mouse and human hepatic organoids.
Introduction
Although the liver has a remarkable regenerative potential, chronic inflammation and scarring severely impair liver regeneration 8 , making organ transplantation the only treatment option for patients with severe liver failure 9 . This therapeutic approach, however, is limited by the lack of liver donors, emphasizing the urgent need for cell-based therapies 10 . A promising alternative to liver transplantation comes from the recent breakthrough that liver organoids can be generated in vitro within animal-derived matrices (e.g. Matrigel) from mouse and human bile duct-derived bi-potential facultative progenitor cells 1, 2, 11 or primary hepatocytes 4, 5 . These organoids are largely composed of progenitor cells that are genetically stable and can be differentiated into functional hepatocyte-like cells, which are able to engraft and increase survival when transplanted in a mouse model of liver disease 1, 2 . However, the batch-to-batch variability of the three-dimensional (3D) matrices currently used for organoid derivation, as well as their mouse tumour-derived origin, makes them unsuited for therapeutic ends. Recent work has suggested that composite matrices of fibrin and laminin-111, optimized for intestinal organoid culture, could also be used for liver organoid growth 12 . Owing to the mouse-tumour derived laminin, these matrices are however incompatible with clinical use, and to the best of our knowledge there is no protocol available to expand and differentiate clinical-grade hepatic organoids 7, 13 .
Results
We previously reported chemically defined 3D matrices for intestinal stem cell culture and organoid derivation 7 , identifying design principles that could be adopted to mimic stem cell niches from different tissues. Here, we sought to develop a synthetic matrix for the efficient proliferation of liver progenitor cells by recapitulating key physical and biochemical characteristics of the hepatic microenvironment. To this aim, we first generated inert poly(ethylene glycol) (PEG) hydrogels enzymatically crosslinked by the activated transglutaminase factor XIIIa (FXIIIa) 14 . To mimic the mechanical properties of the mouse liver, we tuned the stiffness of PEG gels to physiological values (»1.3 kPa) 15, 16 . Key ECM proteins found in the native liver 17 , such as laminin-111, collagen IV and fibronectin, were then incorporated in the PEG network, and soluble factors found in the hepatic niche, such as hepatocyte growth factor (HGF) 18 , the Wnt agonist R-Spondin 2, 19 and fibroblast growth factor 10 (FGF10) 20 , were added to the culture medium, referred to as expansion medium (EM) 2 .
Single dissociated mouse liver progenitor cells derived from Matrigel-expanded liver organoids were embedded into either Matrigel or PEG hydrogels and cultured in EM ( Supplementary   Fig. 1a ). The functionalization of PEG hydrogels with fibronectin and laminin-111 led to efficient organoid generation, comparable to Matrigel (Figs. 1a, b). Replacement of the full-length fibronectin with its minimal integrin recognition peptide RGDSPG (Arg-Gly-Asp-Ser-Pro-Gly) led to similar results, suggesting that the addition of a minimal adhesive moiety to the otherwise inert matrix is sufficient to promote extensive proliferation of liver progenitors (Figs. 1a, b). Cells expanding in PEG hydrogels modified with RGDSPG ('PEG-RGD') generated cystic structures characterized by a central lumen and a surrounding epithelium (Figs. 1c, e). Histology and gene expression analyses showed that these PEG-RGD-derived organoids possess a progenitor phenotype expressing stem/ductal markers such as Lgr5, Epcam, Krt19 and Sox9 (Figs. 1d, e) and, in terms of morphology and gene expression, are indistinguishable from organoids grown in Matrigel (Figs. 1d, e). As expected, markers of fully differentiated hepatocytes such as Cyp3a11 were not expressed ( Fig. 1d) .
A major limitation of all current protocols for culturing epithelial organoids is an obligatory requirement of Matrigel (or similar natural ECM-derived matrices) in the first step of organoid generation. To test whether mouse liver organoids can be established in synthetic matrices without any initial Matrigel culture step, biliary duct fragments were isolated from mouse liver and directly embedded in PEG-RGD hydrogels ( Supplementary Fig. 1a ). Strikingly, after 6 days of culture, organoids emerged that could be serially passaged in culture ( Fig. 1f ). PEG-RGD gels allowed organoid growth for more than 14 days ( Supplementary Fig. 1b ) without any significant structural deterioration. In contrast, Matrigel softened and no longer provided sufficient mechanical support already after 6 days of culture ( Supplementary Fig.1c ), highlighting the importance of having a stably crosslinked matrix for long-term organoid culture.
Liver organoids can be differentiated into functional hepatocyte-like cells when cultured in the presence of specific differentiation medium (DM) containing inhibitors of Notch and TGF-b pathways 2 . To test whether organoids derived in the synthetic matrix preserved the capacity for differentiation and hepatocyte maturation, we grew organoids in PEG-RGD gels and replaced the expansion medium with differentiation medium after 6 days, and analysed the expression of differentiated hepatocyte markers after 12 days 2 . Similar to Matrigel cultures, synthetic gels promoted a robust increase in the transcript levels of mature hepatocyte markers such as Cyp3a11, Alb, Ttr, Nr1h4 (Fxr), Slc2a2 (Glut2), Glul and Nr1h3 (Lxr) ( Fig. 2a and Supplementary Fig. 2b ) and expression of ALB and HNF4a proteins ( Fig. 2b ), while markers of stem cells, such as Lgr5, disappeared ( Supplementary Fig. 2a ). As expected, during the differentiation process, cells acquired a characteristic hepatocyte-like morphology, as evidenced by a polygonal shape and expression of junction proteins such as ZO-1 and E-cadherin (Figs. 2c, d). Occasionally, hepatocyte-like cells showed poly-nucleation, a typical feature of hepatocytes (Figs. 2c, d and Supplementary Fig. 2d ).
Next, to test whether hepatocyte-like cells generated in PEG-RGD hydrogels display hepatocyte-specific functions, we monitored albumin secretion. Liver organoids grown in DM showed a marked increase in albumin secretion, as compared to organoids cultured in EM ( Fig. 2e ).
Moreover, hepatocyte-like cells were able to produce and secrete urea, as well as to accumulate glycogen, two enzymatically-regulated processes that occur in mature hepatocytes (Figs. 2f, g).
Moreover, the majority of differentiated cells were capable of internalizing low-density lipoproteins (LDL) from the culture medium, indicating that LDL receptor-mediated cholesterol uptake is functional ( Fig. 2h ). Altogether, these results demonstrate that liver organoids grown in PEG-RGD hydrogels can be readily differentiated into hepatocyte-like cells that mimic many of the established hepatic functions.
Mechanical signals can play a critical role in controlling stem cell behaviour and tissue homeostasis 21 , but also contribute to the manifestation of diseases [22] [23] [24] . Despite the recent progress in establishing novel 3D liver model systems 2,3,5 , relatively little is known about the role of mechanics in regulating hepatic stem cell biology. To test whether matrix mechanics affect liver organoid growth, we grew organoids in hydrogel of variable stiffness, ranging from values below the normal mouse liver stiffness (0.3 kPa) to those reaching physiological stiffness (1.3 kPa) 15, 16 . Organoid formation efficiency was profoundly affected by the mechanical properties of the matrix, with values mimicking physiological liver stiffness (between 1.3 and 1.7 kPa) being optimal (Figs. 3a, b and Supplementary   Fig. 3a ). Differentiation capacity however was unaffected by the degree of stiffness as induction of hepatic genes was maintained also when liver organoids were differentiated in soft gels ( Supplementary Figs. 2c and 3b ). These data demonstrate that optimizing the mechanical properties of the hydrogel represents a critical step in the efficient generation of liver organoids.
Given the pivotal role of the Hippo pathway nuclear effector, Yes associate protein (YAP), in the transduction of micro-environment mechanical cues downstream of integrins 25 , we next tested whether YAP activation could potentially explain the observed matrix stiffness dependence. We monitored the expression of canonical YAP target genes and YAP subcellular localization in organoids cultured in soft (0.3 kPa) and physiologically-stiff (1.3 kPa) matrices. Interestingly, in stiffer hydrogels, YAP target genes expression and nuclear accumulation were increased compared to soft matrices ( Fig. 3c and Supplementary Fig. 3c ). To examine whether an activated integrin/YAP signalling axis is functionally required for organoid derivation in physiologically-stiff matrices, we treated organoid cultures with PF-573228, an inhibitor of the integrin effector focal adhesion kinase (FAK), or with the YAP inhibitor Verteporfin 26 (Fig. 3d ). Both treatments prevented the increase in organoid formation induced in stiffer matrices ( Fig. 3e and Supplementary Fig. 3d ), indicating that the integrin/YAP module is required in coordinating growth of liver progenitors in response to mechanical stimuli.
We then sought to identify the other components of the FAK-YAP cascade that may play a role in modulating the stiffness response in our system. Since remodelling of the actin cytoskeleton has been identified as a key event upstream of YAP activation [27] [28] [29] , we assessed its putative involvement in physiological stiffness-induced organoid growth by inhibiting acto-myosin contractility with blebbistatin 30 . Surprisingly, blebbistatin treatment significantly enhanced organoid formation ( Fig. 3f ), indicating that matrix stiffness promotes organoid growth independently of cytoskeletal dynamics, and that acto-myosin contractility rather interferes with normal liver progenitor expansion. However, tyrosine phosphorylation of YAP by the Scr family of kinases (SFK), an alternative route for integrin-dependent and acto-myosin independent YAP activation 31, 32 , was increased by matrix stiffness ( Supplementary Fig. 3e ). Of interest, treatment with Dasatinib 33 , a FDAapproved SFK inhibitor, fully abolished YAP phosphorylation and organoid growth in physiologically-stiff (1.3 kPa) matrices ( Fig. 3f and Supplementary Fig. 3e ). These results corroborate the importance of the integrin/SFK/YAP signalling pathway in liver progenitor proliferation in response to differential mechanical inputs.
Liver disease progression is strongly associated with abnormal tissue architecture and mechanotransduction 15, 34, 35 . Indeed, as a direct effect of aberrant ECM deposition in the fibrotic liver, tissue stiffness increases in time and severely compromises its function [36] [37] [38] . In fact, the changes in liver stiffness associated with disease are used for diagnostics based on longitudinal non-invasive monitoring 39 . We reasoned that liver organoids grown in defined hydrogels recapitulating the stiffness of fibrotic liver could serve as physiologically relevant 3D model to investigate how stem cells translate aberrant mechanical inputs into disease-relevant phenotypes. To this aim, we generated fibrosis-mimicking hydrogels with a stiffness of 4 kPa 15, 16 . Strikingly, these hydrogels led to a significant impairment of organoid formation (Figs. 4a-b), demonstrating that an abnormal ECM stiffness is sufficient to decrease the liver progenitor proliferative capacity. In this condition liver organoids showed a reduction in the expression of hepatic progenitor markers ( Fig. 4c ) and upregulation of genes involved in cellular response to hepatic injury ( Fig. 4d ), indicating impaired stemness potential and concomitant induction of a stress response. Finally, fibrosis-mimicking hydrogels led to an increase in the expression of matrix metalloproteases (Figure 4e ), a compensatory phenomenon known to be induced in response to increased ECM stiffness [40] [41] [42] . Surprisingly, in these conditions YAP activation was not affected ( Fig. 4f ), suggesting the existence of other pathways controlling liver progenitor growth in response to increased stiffness. These results suggest that synthetic hydrogels may be a useful tool to assess the contribution of mechanical inputs on liver diseases.
To test the potential clinical relevance of our findings, we assessed whether the PEG-RGD hydrogels, initially designed for expansion and differentiation of mouse liver organoids, were also suitable for culturing human organoids. We first generated Matrigel-derived organoids from human nontumorigenic liver needle biopsies 1, 43 . Human liver progenitor cells were then embedded in PEG-RGD and cultured in human expansion medium (HEM) ( Supplementary Fig. 4a ). In these conditions human liver progenitor cells generated organoids that could be expanded over multiple passages (Fig.   5a ). Similar to mouse, human organoid generation efficiency in PEG-RGD was comparable to Matrigel (Fig. 5a) , and was critically dependent on changes in hydrogel stiffness (Fig. 5b) . Moreover, when cultured in HEM, human liver organoids grown in PEG-RGD expressed progenitor cell markers, such as KRT19 (Fig. 5c ), but readily differentiated into human hepatocyte-like cells when cultured in human differentiation medium (HDM) ( Fig. 5d and Supplementary Fig. 4b ).
Finally, in order to generate clinically relevant human liver organoids, we tested the possibility of establishing organoids from human patients without the interference of any animal-derived matrices. To this aim, freshly isolated liver biopsies from six patients were digested and directly embedded in PEG-RGD hydrogels (Fig. 5e ). Strikingly, after 8 days of culture, organoid formation was scored from progenitor cells of all patients (Fig. 5f ), and could be passaged (Fig. 5g ). Altogether, these data provide proof-of-concept that human liver progenitor cells can be expanded and maintained in vitro within synthetic matrices.
Discussion
We report here the establishment of a fully defined 3D culture system for mouse and human hepatic progenitors and organoids. We demonstrated that liver organoids can be expanded and maintained in such minimal environments with an efficiency that is comparable to Matrigel, but without its main disadvantages of structural instability, batch-to-batch variability and clinical incompatibility. By tuning the stiffness of the synthetic networks to match the physiological levels of the liver, we optimized the efficiency of liver organoid derivation, and identified integrin-SFK-YAP as a mechanosensitive axis that is required for liver organoid growth. Interestingly, in contrast to intestinal organoids 7 , we found that liver progenitor cells transduce mechanical signals in an acto-myosin independent manner and instead require activation of the tyrosine kinase Src to support epithelial tissue formation. Moreover, we used PEG hydrogels to accurately model the aberrant mechanical 
Culture of mouse and human liver organoids from biliary duct fragments and single cells.
Mouse liver organoids were established from biliary duct fragments as previously described with some modifications 2 . Briefly, liver tissues were digested in digestion solution (Collagenase type XI 0.012%, dispase 0.012%, FBS 1% in DMEM medium) for 2 hours. When digestion was complete, Human liver biopsies and generation of human organoids. Human tissues were obtained from patients undergoing diagnostic liver biopsy at the University Hospital Basel. Written informed consent was obtained from all patients. The study was approved by the ethics committee of the northwestern part of Switzerland (Protocol Number EKNZ 2014-099). Ultrasound (US)-guided needle biopsies were obtained with a coaxial liver biopsy technique as described previously 43 . One biopsy cylinder was fixed in formalin and paraffin-embedded for histopathological diagnosis.
Additional cylinders were collected in advanced DMEM/F-12 (GIBCO) for organoid generation.
Patient clinical information are shown in Supplementary Table 2 . Human liver organoids were generated as previously described with some modifications 43 Medium was changed every two days.
Functional analysis. LDL uptake was detected with DiI-Ac-LDL (Biomedical Technologies).
Mouse albumin secretion was detected with ELISA kit (Abcam, ab108792). Urea secretion was assessed with QuantiChrom™ Urea Assay Kit (BioAssay Systems). All experiments were followed according to the manufacturers' instructions.
Statistical analysis and sample information. Statistically significant differences between the means of two groups were assessed by t-test as specified in the legends. All statistical analyses were performed in the GraphPad Prism 7.0 software. A P value of 0.05 or less was considered statistically significant.
Data availability. All summary or representative data generated and supporting the findings of this study are available within the paper. Raw data that support the findings of this study are available upon reasonable request. 
